workup for other potential causes of cardiac fibrosis and reduced left ventricle function including cardiac positron emission tomography (PET) was negative. Based on the presentation and these findings, a diagnosis…
treatment in ARDs. CMR has been successfully used for diagnosis and follow up of cardiac involvement. Furthermore, its role in the identification of arrhythmogenic substrate has been extensively studied…
death (SCD). A case of LVNC with sustained ventricular tachycardia (VT) was presented. An implantable cardiac defibrillator (ICD) was implanted because of the individual’s high SCD risk
June 2018, eleven patients who were candidates for implantation or upgrading of cardiac implantable electronic devices enrolled to do this technique; all patients which were showed to have subclavian vein
beta blockers, inotropes, diuretics, along with upcoming interventional therapies like Cardiac resynchronization therapy (CRT), Implantable cardiac defibrillator (ICD) are currently ceasing the worsening of cardiac…
Implantable Cardioverter Defibrillators (ICDs) have emerged as indispensable guardians of cardiac health; significantly reducing the risk of sudden cardiac death in patients with known ventricular tachycardia or…
Background: Implantable cardioverter-defibrillators (ICDs) are active cardiac implants for immediate treatment of ventricular arrhythmias. They provide life-saving therapy, but may also deliver inappropriate therapy…
According to the product insights, cardiac implants led the overall market in 2018 and cardiac devices is expected to emerge as fastest growing product segment with CAGR of 7.0% from
cardiac device was the pacemaker (35 persons - 85%), instead 5 persons had implantable cardiac defibrillator. One patient had cardiac resynchronization therapy device. Most often the pacemaker was placed near irradiated
Implantable Cardioverter Defibrillators (ICDs) have revolutionized the management of cardiac arrhythmias and have become a cornerstone in the prevention of sudden cardiac death. This study aims to evaluate the impact…
myocardial dysfunction in chronic Heart Failure (HF). Mechanical volume and pressure unloading induced by implantable cardiac assist devices allows a reversal of stress-related compensatory responses of the overloaded…
Background: The deactivation of anti-tachycardia functions of implantable cardiac devices such as pacemakers and defibrillators in end stage disease becomes clinical routine. Uncertainty exists about the deactivation…
unprecedented inherited arrhythmia syndrome which may lead to an increased risk of unexpected cardiac loss of life, in spite of a structurally regular heart. Symptoms include palpitations, syncope, nocturnal agonal…
predispose to infective endocarditis, the common observed risk factors include, congenital heart diseases, implanted medical devices insertion, various cardiothoracic operations as well as immune-compromised patient…
exposing patients to radiation, but it is not feasible in those with cardiac devices. In Western countries, heart involvement accounts for 13 to 25% of sarcoidosis-related deaths ... least 24 months), specific…
higher understanding. Finally, the cutting-edge vogue of the CB, endothelization of the cardiac implants and utilization of prompted human pluripotent stem cells (ihPSCs), is additionally introduced in this review
this review. of collagen proteins for applications in the biomedical field. Human tissue scaffolds, cardiac implantation, wound healing, cornea membranes, dental membrane, dermal filler, cosmetic surgery, etc. can all…
also covered. The use of induced human pluripotent stem cells (ihPSCs) and endothelization of cardiac implants, two contemporary CB trends, are also discussed in this review. The topic
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.